Najat Khan, Chief R&D Commercial Officer: Recursion Pharmaceuticals RXRX Sell · Filed 25/08/19

Trade details

Type: Insider sale
Amount: $202,026.48
Shares · price: 36,599 sh · $5.52 a share
Held after: 668,197 sh
Stock: Recursion Pharmaceuticals RXRX
Person: Najat KhanChief R&D Commercial Officer
Trade date: 25/08/18
Filed: 25/08/19
Days to filing: 1 days

Sold 5.2% of holdings

Share of holding sold: 5.2%

Recursion Pharmaceuticals trades, last 26 weeks

What else happened in Recursion Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/07/19~25/09/17

Najat Khan's recent trades

Najat KhanCEO and President
Planned sale10b5-1 planRecursion Pharmaceuticals
Planned sale10b5-1 plan
Recursion Pharmaceuticals
RXRX
$78.8K
22,408 sh
$78.8K
Filed 09/08
Traded 09/08
Najat KhanCEO and President
Sell10b5-1 planRecursion Pharmaceuticals
Sell10b5-1 plan
Recursion Pharmaceuticals
RXRX
$84.4K
23,588 sh
$84.4K
Filed 06/05
Traded 06/05
Najat KhanCEO and President
Planned sale10b5-1 planRecursion Pharmaceuticals
Planned sale10b5-1 plan
Recursion Pharmaceuticals
RXRX
$84.5K
23,588 sh
$84.5K
Filed 06/05
Traded 06/05
Najat KhanCEO and President
Sell10b5-1 planRecursion Pharmaceuticals
Sell10b5-1 plan
Recursion Pharmaceuticals
RXRX
$94.8K
28,298 sh
$94.8K
Filed 03/11
Traded 03/09
Najat KhanCEO and President
Planned sale10b5-1 planRecursion Pharmaceuticals
Planned sale10b5-1 plan
Recursion Pharmaceuticals
RXRX
$94.7K
28,298 sh
$94.7K
Filed 03/09
Traded 03/09